Severe Sepsis Clinical Trial
Official title:
Comparison of Ultrasound-guided Versus Blind Insertion of Radial Artery Catheters.
Arterial catheterization is frequently performed on critically ill patients for invasive
blood pressure monitoring and/or frequent blood draws, especially arterial blood gas
analysis. The distal part of the radial artery (wrist) is the preferred access site.
The potential complications of the procedure are mostly minor and comprise temporary
occlusion of the radial artery (RA), hematoma, local infection or bleeding from the puncture
site. Major complications including vessel aneurysm or occlusion with threat to hand
viability are rare.
The standard approach to catheterization is "blind" puncture of the RA while locating its
pulse by palpation, followed by threading a 20 Gauge (20G) angio-catheter into the vessel.
Alternatively ultrasound can be used to locate the vessel and guide needle insertion.
To our knowledge, four prospective randomized trials (PRT)5-8 comparing palpation with
ultrasound-guided RA catheterization have been conducted so far and one meta-analysis looked
at the pooled data obtained from these. The results showed that ultrasound guidance
increased the first-attempt success rate at RA catheterization by 71% compared to palpation.
The use of ultrasound also significantly reduced the time to successful catheterization, the
number of punctures as well as the amount of catheters required per procedure.
None of the prior randomized trials has been conducted in an ICU setting and in three out of
the four studies the arterial lines were placed in patients undergoing elective surgery. The
investigators hypothesized that ultrasound could improve first attempt success rate while
placing arterial catheters in an ICU setting. Ultrasound may also reduce total time to
successful insertion and reduce complications.
The investigators plan to randomize patients to either a palpation technique or ultrasound
guided catheter insertion and record the above outcomes.
The study will be conducted in a prospective randomized design on the patient population of
the Surgical Intensive Care Unit (SICU) at Yale New Haven Hospital. All SICU patients in
whom the indication for arterial catheterization has been established by the attending
physician will be eligible for consented randomization to either the "Palpation" or the
"Ultrasound" group.
Once consent from the patient or his/her surrogate has been obtained, eligible patients will
be randomized to either the "Palpation" or the "Ultrasound" group. Sequentially numbered
sealed envelopes will be maintained in the SICU.
Catheter insertion: The side of insertion (left/right arm) is chosen by the operator. The
wrist is positioned by the operator, the skin disinfected and the area draped in a sterile
fashion. "Palpation" group": The artery is punctured after location by palpation only.
"Ultrasound" group": The artery is punctured under real-time ultrasound only with the probe
draped in a sterile sheath. The time from the first skin puncture to confirmed
intra-arterial position of the catheter by observing blood return from the catheter is
measured with a chronometer by a second person. An arterial pressure waveform must be
observed on the monitor to validate intra-arterial catheter placement.
Radial artery cannulation will be performed using the "Radial Artery Catheterization Set
with Integral Needle Protection" (Ref. RA-04020-SP, Arrows International Inc., Reading PA
19605, USA) containing a 20G catheter on a 22 gauge (22G) puncture needle and a 0.46 mm
spring-wire guide.
For ultrasound-guided catheter insertion, operators will use the "Site-Rite 6 Ultrasound
System" with a linear vascular access probe (5-10 MHz) (Bard Access Systems Inc., 605 North
5600 West, Salt Lake City, UT 84116, USA).
Operators: RA catheterization is a typical teaching procedure frequently performed in the
ICU. In our unit, arterial lines are placed by either post graduate year 2 (PGY-2) residents
(surgery & anesthesia) rotating through the SICU on a monthly basis, or by mid-level
providers who are in the unit for indeterminate periods of time. For our study, this will be
an important point, as one of our goals will be to demonstrate a learning effect, which is
less likely to be observable among the PGY-2 residents who will be present in the unit for a
month only.
All operators will get instructions (lecture and hands-on training on vascular phantom at
the beginning of their SICU rotation) on the use of ultrasound for vascular access and will
at all times have the opportunity to exercise their skills on a vessel phantom. Each
successful vessel puncture on the vessel phantom must be recorded by the operator, including
time and date. For each operator performing the ultrasound-guided insertion on a patient,
one of the investigators will be present for supervision and data collection, but not for
assistance with insertion, unless required for failure after having used both methods.
Cross-over: After three failed attempts at catheterization with the allocated first method,
the alternative method must be used; the operator can opt to puncture the RA on the opposite
arm. Timing of the first method ends when the operator decides to abandon the third attempt.
Timing for the new method starts at the new first skin puncture.
Follow up: All catheters will be monitored daily and on days 1 and 3 with clinical and
ultrasound examination for the development of complications. The catheter will be followed
daily for functional outcomes defined as the quality of the arterial waveform on the monitor
and the ability to draw blood from the catheter. The day on which the catheter ceases to
function for each of these purposes will be recorded as well as the day of catheter removal.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04804306 -
Sepsis Post Market Clinical Utility Simple Endpoint Study - HUMC
|
||
Completed |
NCT04227652 -
Control of Fever in Septic Patients
|
N/A | |
Recruiting |
NCT04005001 -
Machine Learning Sepsis Alert Notification Using Clinical Data
|
Phase 2 | |
Recruiting |
NCT02899143 -
Short-course Antimicrobial Therapy in Sepsis
|
Phase 2 | |
Completed |
NCT02539147 -
Characterization of Non-canonical Way in Inflammasome Monocytes of Patients With Severe Sepsis
|
N/A | |
Completed |
NCT01932814 -
Acute Kidney Injury in Septic Critically Ill Patients : Are Aminoglycosides Really Harmful?
|
N/A | |
Completed |
NCT01929772 -
German Lactat Clearance in Severe Sepsis
|
N/A | |
Completed |
NCT01449721 -
Preemptive Resuscitation for Eradication of Septic Shock
|
N/A | |
Active, not recruiting |
NCT01162109 -
Zinc Therapy in Critical Illness
|
Phase 1 | |
Not yet recruiting |
NCT01211899 -
4G/5G Polymorphism of Plasminogen Activator Inhibitor-1 Gene and Disseminated Intravascular Coagulation in Severe Sepsis and Septic Shock
|
N/A | |
Completed |
NCT00934011 -
Use of Inflammatory Biomarkers to Guide Antibiotic Therapy in Patients With Severe Infections
|
N/A | |
Recruiting |
NCT00335907 -
Protocol-driven Hemodynamic Support for Patients With Septic Shock
|
N/A | |
Completed |
NCT00463645 -
Investigation of Correlation Between Interstitial and Arterial Blood Glucose Concentrations in Septic Patients
|
N/A | |
Completed |
NCT02361528 -
GM-CSF to Decrease ICU Acquired Infections
|
Phase 3 | |
Completed |
NCT02734550 -
(1,3)-β-D-glucan Based Diagnosis of Invasive Candida Infection in Sepsis
|
N/A | |
Completed |
NCT02973243 -
The Vital Signs to Identify, Target, and Assess Level (VITAL) Care Study III
|
N/A | |
Terminated |
NCT03895853 -
Early Metabolic Resuscitation for Septic Shock
|
Phase 2 | |
Completed |
NCT01945983 -
Early Use of Norepinephrine in Septic Shock Resuscitation
|
N/A | |
Completed |
NCT01598831 -
Phase 3 Safety and Efficacy Study of ART-123 in Subjects With Severe Sepsis and Coagulopathy
|
Phase 3 | |
Enrolling by invitation |
NCT02258984 -
Can the Venus 1000 Help Clinicians Treat Patients With Severe Sepsis or Acute Heart Failure? The CVP Trial
|
N/A |